Cintas Co. (NASDAQ:CTAS) – Investment analysts at William Blair raised their Q1 2020 earnings estimates for Cintas in a research note issued on Thursday, June 20th, Zacks Investment Research reports. William Blair analyst T. Mulrooney now anticipates that the business services provider will post earnings of $1.97 per share for the quarter, up from their previous estimate of $1.89. William Blair has a “Buy” rating on the stock. William Blair also issued estimates for Cintas’ Q3 2020 earnings at $1.87 EPS and Q4 2020 earnings at $2.30 EPS.

CARREFOUR SA/S (OTCMKTS:CRRFY) – Analysts at Jefferies Financial Group lifted their FY2019 earnings per share estimates for CARREFOUR SA/S in a research report issued to clients and investors on Wednesday, June 26th, according to Zacks Investment Research. Jefferies Financial Group analyst J. Grzinic now forecasts that the company will post earnings of $0.25 per share for the year, up from their prior estimate of $0.24. Jefferies Financial Group also issued estimates for CARREFOUR SA/S’s FY2020 earnings at $0.27 EPS and FY2021 earnings at $0.28 EPS.

Rosetta Stone Inc (NYSE:RST) – Analysts at Barrington Research cut their Q2 2019 EPS estimates for shares of Rosetta Stone in a research report issued on Monday, June 17th, Zacks Investment Research reports. Barrington Research analyst A. Paris. Jr now expects that the software maker will post earnings of ($0.31) per share for the quarter, down from their prior forecast of ($0.17). Barrington Research currently has a “Buy” rating and a $29.00 target price on the stock. Barrington Research also issued estimates for Rosetta Stone’s Q3 2019 earnings at ($0.16) EPS, Q4 2019 earnings at ($0.15) EPS and FY2019 earnings at ($0.64) EPS.

Cellular Biomedicine Group Inc (NASDAQ:CBMG) – Analysts at Cantor Fitzgerald issued their FY2019 earnings per share estimates for Cellular Biomedicine Group in a research report issued to clients and investors on Tuesday, June 25th, according to Zacks Investment Research. Cantor Fitzgerald analyst V. Kumar forecasts that the biotechnology company will post earnings of ($2.05) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $27.00 target price on the stock. Cantor Fitzgerald also issued estimates for Cellular Biomedicine Group’s FY2020 earnings at ($2.05) EPS.

Prestige Consumer Healthcare Inc (NYSE:PBH) – Jefferies Financial Group upped their Q1 2020 earnings estimates for Prestige Consumer Healthcare in a note issued to investors on Tuesday, June 25th, according to Zacks Investment Research. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings of $0.65 per share for the quarter, up from their prior forecast of $0.61. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q3 2020 earnings at $0.78 EPS.

Golden Prospect Precious Metals Ltd. (LON:GPM)’s stock price shot up 2.4% on Thursday . The company traded as high as GBX 26 ($0.34) and last traded at GBX 25.50 ($0.33), 142,333 shares traded hands during mid-day trading. An increase of 176% from the average session volume of 51,504 shares. The stock had previously closed at GBX 24.90 ($0.33).

Shares of RediShred Capital Corp. (CVE:KUT) shot up 1% during trading on Thursday . The company traded as high as C$1.05 and last traded at C$1.05, 10,700 shares traded hands during mid-day trading. A decline of 65% from the average session volume of 30,534 shares. The stock had previously closed at C$1.04.

Livermore Investment Group Limited. (LON:LIV)’s share price shot up 4.5% during trading on Thursday . The company traded as high as GBX 44 ($0.57) and last traded at GBX 42 ($0.55), 66,211 shares were traded during mid-day trading. An increase of 903% from the average session volume of 6,604 shares. The stock had previously closed at GBX 40.20 ($0.53).

Standard Life Private Equity Trust PLC (LON:SLPE)’s stock price shot up 0.3% during trading on Thursday . The stock traded as high as GBX 339 ($4.43) and last traded at GBX 334 ($4.36), 59,243 shares traded hands during mid-day trading. A decline of 26% from the average session volume of 80,266 shares. The stock had previously closed at GBX 333 ($4.35).

Roots Corporation (TSE:ROO) – Equities research analysts at National Bank Financial decreased their Q2 2020 earnings per share (EPS) estimates for Roots in a research report issued to clients and investors on Wednesday, June 12th, according to Zacks Investment Research. National Bank Financial analyst V. Shreedhar now forecasts that the company will earn ($0.11) per share for the quarter, down from their prior forecast of ($0.08). National Bank Financial currently has a “Outperfrom Under Weight” rating on the stock. National Bank Financial also issued estimates for Roots’ Q1 2021 earnings at ($0.20) EPS and Q2 2021 earnings at ($0.11) EPS.